© 2025. The Trustees of Indiana University
Copyright Complaints
1229 East Seventh Street, Bloomington, Indiana 47405
News, Arts and Culture from WFIU Public Radio and WTIU Public Television
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Some web content from Indiana Public Media is unavailable during our transition to a new web publishing platform. We apologize for the inconvenience.

Baxter BioPharma Solutions to rename to "Simtra", new developments underway

BioPharma Solutions, previously owned by Baxter International Inc., was sold to Advent International and Warbug Pincus in May. As part of the $4.25 billion deal, Baxter’s BioPharma Solutions will be renamed Simtra BioPharma Solutions.

Read more: Baxter selling off BioPharma wing to equity investment firms

It will now be a fully independent contract development and manufacturing organization (CDMO), but will continue to ensure supply of pharmaceutical products to customers.

Simtra said it will focus on community-based growth, as the Bloomington facility plans to bring new job opportunities to the region.

By partnering with pharmaceutical and biotech companies, the business will specialize in sterile injectables to provide scientific help. The goal is to solve injectable medicine production issues, according to an email from Simtra to WFIU/WTIU News.

Simtra has about 1,700 employees who will continue working at manufacturing sites in Bloomington and Germany, as well as at corporate headquarters, which is under development in New Jersey.

The Bloomington facility has been in operation for 27 years under the Baxter name, and is now one of the largest contract manufacturers of sterile products in North America.

Sara Molina is a journalist for Indiana Public Media. She has previously worked as a reporter for the Indiana Daily Student. She is from Northwest Indiana and lives in Bloomington, attending IU as a junior journalism major.